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Introduction: COVID-19 is a respiratory disease caused by infection with the virus, SARS-
CoV-2. Transmission of the virus can occur in both symptomatic and asymptomatic cases 
making controlling the spread challenging. Point prevalence testing in long term care facilitates 
has been found to be a useful strategy in detecting cases and managing COVID-19 outbreaks. 
The impact of this control strategy on severe outcomes of disease in residents of these facilities 
has not been fully characterized. 
Methods: Active surveillance of COVID-19 in long term care facilities in Connecticut began in 
April 2020, with point prevalence surveys beginning in May 2020. Data was collected for 34 
facilities from a statewide surveillance system and confirmed through Connecticut’s Electronic 
Disease Surveillance System. Data from April 2020 to December 2020 was analyzed to assess 
the association between point prevalence testing and severe outcomes. 
Results: Overall, there were 2,244 PCR positive residents in 34 facilities between April 2020 
and December 2020. Of this group 18.4 % were hospitalized and 25.9% died. Increasing age and 
hospitalization were significantly associated with an increased risk of mortality (p<0.001) while 
males had a significantly higher risk of hospitalization (p<0.001). The number of point 
prevalence surveys conducted by a facility was not significantly associated with either the case 
fatality ratio or hospitalization rate within the facility. 
Conclusions: Understanding the benefits of point prevalence surveys in LTCFs is important 
when looking at the cost effectiveness of the survey and creating recommendations and policies. 
There was no association found between the number of point prevalence studies and severe 
disease outcomes of residents. Future studies could further investigate the association between 
the reason for testing a resident and severe disease outcomes.  
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Introduction 
Outbreaks in long term care facilities (LTCF) pose a unique challenge to public health 
interventions and infection control. Resident factors and facility characteristics contribute to an 
increase in spread of infectious diseases and severe outcomes in infected individuals1. Symptom 
screening, testing of residents, linkage to care, isolation and good infection control are all 
strategies that can be used to manage outbreaks in these settings2,3. Detection based on 
symptoms, however, is not as reliable of a strategy when transmission is occurring through 
asymptomatic individuals.  
 
First recognized in December 2019, COVID-19 is a respiratory disease caused by infection with 
the virus, SARS-CoV-2. Infection with the virus has been shown to be both symptomatic and 
asymptomatic with transmission occurring in both4. Symptomatic cases typically manifesting 
with fever, cough, congestion, and fatigue4. Atypical symptoms, such as altered mental status 
and gastrointestinal symptoms, are frequently seen in elderly patients5. During the COVID-19 
pandemic, approximately 40% of infections in LTCFs have been asymptomatic, indicating the 
need to use additional methods to detect and isolate cases5-7. Point prevalence testing has been 
found to be a useful strategy in detecting cases and managing COVID-19 outbreaks6,8-10. 
 
Residents of LTCFs are typically elderly with multiple comorbid conditions making them highly 
vulnerable to COVID-191,2,11. These facilities have been disproportionately impacted by 
COVID-19, accounting for 61.6% of deaths in Connecticut during the first two months of the 
pandemic3,6. The first case of COVID-19 in a Connecticut LTCF was reported on March 15, 
2020 and statewide surveillance for COVID-19 in long term care facilities was established in 
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Connecticut by April 15, 2020 via the Facility Licensing and Investigations Section (FLIS) 
reportable events portal of the Connecticut Department of Public Health (CT DPH). The CT 
DPH began to recommend point prevalence testing (PPS) of LTCF residents on May 11, 202012. 
In accordance with CDC guidelines, facilities were encouraged to test previously negative 
residents weekly until there were no new positives for at least 14 days13. At this time, facilities 
with active outbreaks were trained on proper infection control and cohorting of positive 
residents. 
 
Previous analyses of these point prevalence surveys (PPS) found a high proportion of 
asymptomatic infections6 and a significant association of PPS to decreased incidence rates14. 
Studies have found support for decreased mortality rates by increased case detection from 
frequent testing15 and better outcomes for residents found through PPS compared to symptomatic 
testing16. The impact of serial PPS on severe outcomes has largely gone unevaluated, except for 
a few studies conducted on a small sample of nursing homes15,16.  This study seeks to build 
evidence for the protective nature of serial resident PPS against hospitalization and mortality 
among LTCF residents. This information could be beneficial in understanding the utility of 
repeated prevalence testing and informative of decisions related to policy and cost-effectiveness. 
 
Methods 
Point prevalence testing for SARS-CoV-2 in long term care facilities began in May 2020 with 
delivery of specimen collection kits beginning on May 2nd. Kits were distributed with the help of 
the Connecticut National Guard and CDC. The testing for the PPS consisted of molecular SARS-
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CoV-2 testing through nasopharyngeal (NP) swabs of all residents who had not tested positive 
within 90 days and all staff within a facility. Due to limited resources early in the pandemic, 
34/212 LTCFs in Connecticut (16%) were prioritized for testing based on the current number of 
cases they had, licensed bed size, and ability to impact the spread within the facility6. These 34 
facilities comprised the sample for this analysis. 
 
A statewide surveillance system for COVID-19 in all LTCFs was initiated by CT DPH on April 
15, 2020. Staff in each facility were required to answer daily questionnaires regarding facility 
level data and input individual level data on all cases in a web-based portal (FLIS) maintained by 
DPH. Baseline information on the surveys was obtained from this portal and confirmed by phone 
for any PPS conducted from May 2020–December 18th 2020. December 18th, 2020 was chosen 
as the end date for this analysis to control for any impact vaccination may have had on 
hospitalization and mortality. Individual-level demographic information, hospitalization and 
mortality status were also extracted from the portal. The demographic information and test 
results reported by the LTCF staff were then confirmed in Connecticut’s Electronic Disease 
Surveillance System (CTEDSS). Death information reported by the Office of the Chief Medical 
Examiner (OCME) is imported into CTEDSS as well and any deaths reported by the LTCF were 
checked against this database. 
 
Cases for analysis were restricted to only residents with a PCR positive test result. Case fatality 
ratios (CFRs) for each facility were calculated by summing the number of PCR positive test 
results and deaths reported to the line list of each facility. Published counts on DPH weekly 
reports did not always match the ones pulled from FLIS due to the exclusion of suspect and 
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probable cases from this analysis.  The hospitalization rate was calculated for each facility by 
dividing the number of positive residents that were hospitalized by the total number of positive 
residents. Mortality was described and compared with respect to demographic characteristics and 
hospitalization status utilizing ANOVA and chi-square tests.  Multivariable logistic regression to 
assess the association of age, race, and gender with hospitalization and mortality were conducted. 
Hospitalization status was also included in the multivariable logistic regression for mortality. A 
correlation analysis was also conducted to examine the relationship between the number of PPS 
conducted and the CRF and hospitalization rates at the facilities. Analyses and figures were 
performed in RStudio version 1.2.1335 using R version 3.6.1. 
 
Results 
Between April 15th and December 18th 2020, there were 2,244 PCR positive residents in the 34 
LTCFs. Overall, 18.4% of the PCR positive residents were hospitalized and 25.9% of PCR 
positive residents died (Table 1). Age and hospitalization were significantly associated with 
mortality status (p<0.001). Of those with available demographic information, 83% were non-
Hispanic white, 12% were Black or African American, and 3% were Hispanic. The majority of 
positive residents in the sample were female (65%) and the average age was 80.8 ± 12.1 years 
Within the 34 facilities, a median of 10 point prevalence surveys were conducted (range 3 to 17). 
 
Demographic characteristics associated with hospitalization 
The number of hospitalizations per facility ranged from 0 cases to 27 cases with a median of 11 
cases. In an unadjusted logistical regression, there was a significant association between Black or 
 10 
African American race and hospitalization, with this group having 2.59 (95% CI 1.93, 3.45) 
times the odds of being hospitalized compared to whites (Table 2). There was no significant 
association seen among the other race/ethnicity groups. A statistically significant increased risk 
of hospitalization was also seen among males, with men having 1.78 (95 % CI: 1.43, 2.21) times 
the odds of being hospitalized compared to females (Table 2). A statistically significant 
association between two age groups and hospitalization was also seen. Those aged 81–90 years 
old had 0.73 (95% CI: 0.55, 0.98) times the odds of hospitalization compared to those less than 
70 years or younger while those 91 years and older saw 0.30 (95% CI: 0.21, 0.43) times the odds 
of hospitalization compared to those 70 years or younger. Individuals aged 71-80 did not see a 
significant difference in hospitalization compared to those 70 years or younger. Odds ratios were 
adjusted using a multivariable logistic regression model. The full model included age, sex, and 
race/ethnicity. When adjusted for these variables, older age, male, and Black or African 
American remained statistically associated with hospitalization (Table 3). Of these, being male 
and Black or African American were associated with an increased risk of hospitalization 
compared to being female or White while being older was associated with a decreased risk. 
 
Demographic characteristics associated with mortality 
Age and hospitalization were both significantly associated with mortality (p<0.001, Table1). 
Gender and race/ethnicity were not significant. As age groups increased, the odds of dying 
increased as well. Those 90 years or older had the highest odds, with this group experiencing 
3.83 (95% CI 2.78, 5.36) times the odds of death compared to those 70 years or younger (Table 
4). Residents that were hospitalized had 3.5 (95% CI 2.80, 4.38) times the odds of death 
compared to those who were not hospitalized (Table 4). Upon adjustment for age, sex, 
 11 
race/ethnicity and hospitalization using a multivariable logistic regression model, a statistically 
significant association was seen between sex and death. Males had 1.49 (95% CI 1.16, 1.80) 
times the odds of death compared to females (p=0.001) (Table 5). Hospitalization and age 
remained significantly associated with death upon adjustment (Table 5). 
 
Impact of point prevalence surveys  
In order to analyze age in relation to point prevalence surveys, the median age at each of the 34 
facilities was calculated. The median of facility median ages was 82 years (range 71 to 90 years). 
The median case fatality ratio (CFR) among the 34 facilities was 26.3% (range 5.4 to 45%) and 
the median percent of residents hospitalized among cases was 16.8% (range 0.0 to 38.5%). A 
slight downward trend was observed between the number of PPS conducted and the rate of 
hospitalization (R= -0.17) but this was not significant (p=0.32) (Figure 1). No significant 
relationship was observed between CFR and the number of PPS conducted (R=0.052, p=0.77) 
(Figure 2). A Poisson regression model showed no significant relationship between the number 
of PPS conducted and the percent hospitalized. Additionally, no significant relationship was seen 
between the number of PPS conducted and the CFR. 
 
Discussion 
This analysis looked at both individual and facility level hospitalization and mortality 
information among COVID-19 positive residents in a subset of LTCFs. The median case fatality 
ratio (26.3%) was similar to those seen in other studies, however the median rate of 
hospitalization (16.8%) among positive residents was lower17. These rates varied largely by 
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facility, with some having substantially higher rates. The facility with the highest case fatality 
ratio, 45%, had a higher median age of residents compared to other facilities at 90 years. Age 
may have been a contributing factor to the increased mortality rate in this facility compared to 
others.  
 
Age was not consistently associated with hospitalization and mortality among PCR-positive 
residents. Decreasing odds of hospitalization was observed with increasing age while there were 
increasing odds of death. This contrasts with what has been seen in the general population with 
COVID-19 where the risk of death and hospitalization both increase with age18,19. This 
difference in risk levels may be specific to long-term care facility residents. These residents are 
often older and suffering from more comorbidities compared to the general population, putting 
them at risk for more severe COVID-19 outcomes20. The decision about whether or not to send a 
resident out to the hospital may be influenced by other factors in addition to how severe their 
illness is21. Residents who are older may already be receiving end of life care or families and 
residents may decline hospitalization, leading to decreased rates. A more qualitative analysis 
may be beneficial in identifying the driving factors behind this relationship. Mehta et al. also 
found this opposing pattern of death and hospitalization rates in their study of US nursing home 
residents22.  
 
Looking at other demographic characteristics, males saw significantly higher odds of 
hospitalization compared to females. This finding was consistent with previous studies18,19,22. 
Males also experienced significantly higher odds of mortality compared to females when 
adjusted for age, race, and hospitalization status. These findings may be partially explained by 
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immune differences and could provide evidence for the need to further study the differences in 
outcomes by sex23. Consistent with other studies, Black or African American residents 
experienced higher odds of hospitalization but not death19,22. The hospitalization of a resident 
was associated with significantly increased odds of mortality in both adjusted and unadjusted 
models. Residents that are transferred to the hospital are more likely to be have severe disease 
compared to those who remain in the facility. Studies have also shown transfers to be associated 
with a higher rate of complications compared to residents remaining in the facility, which may 
also play a role in the increased odds of mortality24.  
 
Point prevalence surveys are one way for facilities to improve infection prevention during 
outbreaks of infectious diseases where a high number of infectious cases are unable to be 
detected symptomatically. Previous studies have provided evidence that these surveys are have 
associated with decreased incidence rates and mortality rates, as well as better outcomes among 
residents6,15,16. This analysis did not find any association between point prevalence surveys and 
decreased case fatality ratios or hospitalization rates among positive residents. This may be due 
to the inability to account for factors such as comorbidities or the change in rates of mortality 
and hospitalizations over time. Nursing homes were severely affected early in the pandemic, and 
a large number of cases were found in the first point prevalence study. Over time, treatment and 
detection of cases was improved as an understanding of the disease developed. This may have 
led to improved case fatality ratios and hospitalization rates over time that may have been 
averaged out by earlier rates.   
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One limitation of this analysis is missing or incomplete data due to inconsistent and delayed 
reporting by nursing homes. Additionally, testing of residents was difficult early in the pandemic 
due to lack of available resources. This contributed to an underestimation of cases, related 
hospitalization, and related deaths as this analysis was restricted to only PCR-positive 
individuals. Future analysis could compare the outcomes of suspect and probable cases to those 
who were confirmed to further explore the relationship between case detection through testing 
and COVID-19 outcomes. The homes selected for analysis were prioritized early on due to high 
numbers of unknown cases and were all of average size and quality. Future studies could look at 
a random sample to increase variation and investigate the impact of PPS under varying 
conditions. Information on the reason for testing of each resident was not available for all 
residents, so residents found through symptomatic testing or point prevalence surveys were not 
able to be separated. This distinction would be important in further analysis. 
 
As the pandemic continues, it will be important to fully understand the benefits of point 
prevalence surveys in LTCFs, particularly when looking at the cost effectiveness of the survey 
and creating policies. Current information on the benefit is mixed with some studies finding 
improvements in outcomes while this one found no impact. Future studies are warranted to help 
guide recommendations on when and for what purpose LTCFs should conduct PPS. These 
studies could look more closely at reasons for testing individual residents and include 
information on comorbidities.  
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Tables and Figures: 
 
Table 1.  Description of the Sample, by Mortality Status* 
Characteristic Not deceased (n = 1,663) 
Deceased 
(n = 581) p
† 
Age (years), mean ± SD 79.4 ± 12.4 84.7 ± 10.4 <0.001 
Sex, n (%)   0.088 
     Female 1106 (66.5) 363 (62.5)  
     Male 557 (33.5) 218 (37.5)  
Race, n (%)   0.197 
     White 1314 (82.3) 480 (83.6)  
     Black or African American 181 (11.3) 71 (12.4)  
     Hispanic 59 (3.7) 12 (0.2)  
     Other 42 (2.6) 11 (1.9)  
Hospitalized, n (%)   <0.001 
     Yes 214 (12.9) 198 (34.1)  
     No 1449 (87.1) 383 (65.9)  
 
* Numbers may not sum to totals due to missing data, and column percentages may not sum to 
100% due to rounding. 
† P-value for analysis of variance F-test (continuous variable) or χ2 test (categorical variable). 
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Table 2.  Unadjusted associations between study variables and hospitalization 
Characteristic N* n (%) Hospitalized OR (95% CI) 
Race/ethnicity    
     White 1,794 295 (16.4) 1.00 
     Black or African American 252 85 (33.7) 2.59 (1.93, 3.45) 
     Hispanic 71 16 (22.5) 1.48 (0.81, 2.55) 
     Other 53 12 (22.6) 1.49 (0.74, 2.78) 
Age (years)    
     <70 448 111 (24.8) 1.00 
    71-80 546 113 (20.7) 0.79 (0.59, 1.07) 
    81-90 724 141 (19.5) 0.73 (0.55, 0.98) 
    >90 526 47 (8.93) 0.30 (0.21, 0.43) 
Sex    
     Female 1469 224 (15.2) 1.00 
     Male 775 188 (24.3) 1.78 (1.43, 2.21) 




Table 3.  Multivariable logistic regression model of factors associated with hospitalization 
(N=2,244) 
Characteristic Adjusted OR (95% CI) p 
Race/ethnicity   
     White 1.00 --- 
     Black or African American 2.32 (1.72, 3.11) <0.001 
     Hispanic 1.18 (0.64, 2.06) 0.584 
     Other 1.27 (0.63, 2.41) 0.479 
Age 0.98 (0.97, 0.99) <0.001 
Sex   
     Female 1.00  --- 





Table 4.  Unadjusted associations between study variables and mortality 
Characteristic N* n (%) Deceased OR (95% CI) 
Race/ethnicity    
     White 1,794 480 (26.8) 1.00 
     Black or African American 252 71 (28.2) 1.07 (0.796, 1.43) 
     Hispanic 71 12 (16.9) 0.56 (0.28, 1.01) 
     Other 53 11 (20.8) 1.72 (0.35, 1.35) 
Age (years)    
     <70 448 58 (12.9) 1.00 
    71-80 546 120 (22.0) 1.89 (1.35, 2.68) 
    81-90 724 212 (29.3) 2.78 (2.04, 3.86) 
    >90 526 191 (36.3) 3.83 (2.78, 5.36) 
Sex    
     Female 1469 363 (24.7) 1.00 
     Male 775 218 (28.1) 1.19 (0.98, 1.45) 
 Hospitalized    
     No 1,832 383 (20.9) 1.00 
     Yes 412 198 (48.1) 3.5 (2.80, 4.38) 
* Numbers may not sum to total due to missing data. 
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Table 5.  Multivariable logistic regression model of factors associated with mortality (N=2,244) 
Characteristic Adjusted OR (95% CI) P 
Race/ethnicity   
     White 1.00 --- 
     Black or African American 1.04 (0.75, 1.43) 0.797 
     Hispanic 0.62 (0.30, 1.15) 0.151 
     Other 0.77 (0.35, 1.51) 0.452 
Age 1.06 (1.05, 1.07) <0.001 
Hospitalized   
     No 1.00 --- 
     Yes 4.59 (3.59, 5.90) <0.001 
Sex   
     Female 1.00  --- 




Figure One: Correlation of Facility Hospitalization Rate to Number of PPS Complete 
 




Figure 2: Correlation of Facility Case Fatality Ratio to Number of PPS Complete 
 
*Shading represents 95% CI 
